The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,380.00
Bid: 12,378.00
Ask: 12,382.00
Change: 48.00 (0.39%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EC chief warns Astra must honour contract before exporting doses

Fri, 26th Mar 2021 05:59

(Alliance News) - The European Commission president has warned AstraZeneca PLC that it must "honour" its vaccine contract with the bloc before exporting doses elsewhere in the world.

Ursula von der Leyen urged "transparency" from other countries, but did not confirm if the EU would bring in tougher export restrictions on coronavirus jabs, amid a row over supplies with the British-Swedish pharmaceutical giant.

However, she acknowledged that worldwide supply chains needed to remain "intact" for vaccine production, while some European leaders appeared optimistic that the UK and EU could soon resolve their dispute over supplies.

Elsewhere, UK Prime Minister Boris Johnson sought to calm fears over the possible introduction of coronavirus certificates after publicans criticised his suggestion that it may be up to landlords to decide to request proof of vaccination in venues.

Just days after the prime minister flagged tougher measures to prevent Covid-19 variants being transmitted from Europe, the Telegraph reports the government is planning to implement a mass testing regime for lorry drivers arriving in the UK.

Earlier, addressing a Brussels press conference following a meeting of the European Council on Thursday, von der Leyen said she had "no knowledge" of the UK exporting jabs, while 77 million doses had been exported to 33 countries by the EU so far.

It came after the European Commission set out a tougher regime to stem supplies of jabs to nations faring better in the pandemic as the bloc's states faced a third wave of cases.

von der Leyen told reporters: "Companies have to honour their contract to the EU before they export to other regions in the world. This is of course the case with AstraZeneca.

"I think it is clear that the company [AstraZeneca] has to catch up and honour the contract it has with the EU member states before it can engage again in exporting vaccines."

She added: "We have worldwide supply chains that have to be intact and it is of the utmost importance that we get back to an attitude of openness."

Asked about how many vaccines the UK had exported, von der Leyen told reporters: "I have no knowledge so far of UK exports, perhaps I am mistaken and waiting for their transparency."

Following the summit, Belgian Prime Minister Alexander de Croo said that he believed the EU's dispute with the UK over vaccine supplies "can be resolved" as he referred to a phone call with Johnson last week.

"We think that the discussion we have with the UK can be resolved based on good agreements," de Croo told a Brussels press conference.

Striking a similar tone, Dutch Prime Minister Mark Rutte said that he was "cautiously optimistic" that divisions between the UK and the EU could be resolved.

"I think that on Saturday or soon after, they could come to an agreement which would be very helpful because we are friends, the UK and the rest of Europe, and we need each other," he told reporters.

But leaders appeared to be divided on the issue following the summit, with French president Emmanuel Macron insisting that the EU is "no longer naive" with its export controls tool.

It came after Johnson acknowledged the "moral complexities" around a domestic coronavirus certificate and suggested that it might only be possible to introduce one after all adults had been offered a vaccine at the end of July.

The government will say more on the possible use of Covid status certificates in early April, which could be based on whether people have developed antibodies through infection, as well as vaccinations and negative tests.

But landlords rejected their use after the PM's earlier suggestion it could be up to them to decide whether to screen customers' certificates on entry.

A mobile phone app which features a scannable QR code could be used to provide a virtual coronavirus certificate for entrance into pubs, clubs and restaurants, according to the Daily Mail.

Measures to implement Johnson's "road map" out of lockdown, which will see England's restrictions eased in a series of stages over the coming months, were passed without a vote.

But a series of Tory MPs refused to back a six-month extension to emergency powers contained in the Coronavirus Act after Health Secretary Matt Hancock was unable to say whether they would definitely expire after that.

Some 76 MPs voted to oppose the extension of the laws, although the measure passed with a majority of 408.

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.